Eli Lilly’s Orforglipron Data Is Not Disastrous: Analyst – Eli Lilly (NYSE:LLY)
Eli Lilly and Co LLY released underwhelming data from a Phase 3 ATTAIN-1 trial evaluating orforglipron, an investigational…
Is Trump Playing With Inflation Data?
Whispers of government manipulation are swirling after a quiet change in how inflation is measured. Since May, just…